The US Federal Trade Commission is probing DaVita Inc. and Fresenius Medical Care AG over allegations that they made it hard for physicians to leave for rivals and start new businesses, Politico reported on Saturday.
The agency is examining the business models of the two companies, which are leaders in the US dialysis market, reported Politico, which cited people with knowledge of the investigations. The probe is looking into whether noncompete agreements the companies required doctors to sign hindered efforts by rivals that would make it easier for dialysis patients to be treated at home.
